Micro opioid receptor A118G polymorphism and post-operative pain: Opioids' effects on heterozigous patients

International Journal of Immunopathology and Pharmacology

Volumn 24, Issue 4, 2011, Pages 993-1004

  De Capraris, Antonella ^a   Cinnella, G ^a   Marolla, A ^a   Salatto, P ^a   Da Lima, S ^a   Vetuschi, P ^a   Consoletti, L ^a   Gesualdo, L ^a   Dambrosio, M ^a  

^a University Hospital of Foggia   (Italy)

Author keywords

118A> G polymorphism, cortisol; Postoperative pain; opioid receptor

Indexed keywords

FENTANYL; HYDROCORTISONE; KETOROLAC; LEVOBUPIVACAINE; ONDANSETRON; OPIATE RECEPTOR; RANITIDINE; ROPIVACAINE; SUFENTANIL; TRAMADOL; MORPHINE; MU OPIATE RECEPTOR; OPIATE;

ADULT; ANALGESIA; ANALGESIC ACTIVITY; ARTICLE; CESAREAN SECTION; CLUSTER ANALYSIS; CONTINUOUS EPIDURAL ANESTHESIA; CONTINUOUS INFUSION; CONTROLLED STUDY; DISEASE COURSE; DRUG EFFICACY; FEMALE; GENE FREQUENCY; GENERAL ANESTHESIA; GENETIC ASSOCIATION; GENOTYPE; HETEROZYGOSITY; HETEROZYGOTE; HORMONE RESPONSE; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PAIN ASSESSMENT; POSTOPERATIVE NAUSEA AND VOMITING; POSTOPERATIVE PAIN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SINGLE NUCLEOTIDE POLYMORPHISM; SURGICAL TECHNIQUE; TREATMENT RESPONSE; VISUAL ANALOG SCALE; AGED; COMPARATIVE STUDY; DRUG EFFECT; DRUG RESPONSE; EPIDURAL ANESTHESIA; GENETIC ANALYSIS; HOMOZYGOSITY; HORMONE RELEASE; HYDROCORTISONE BLOOD LEVEL; INTRAOPERATIVE PERIOD; MIDDLE AGED; OBSERVATIONAL STUDY; PHARMACOGENETICS; POLYMERASE CHAIN REACTION; POSTOPERATIVE ANALGESIA;

EID: 84856588142     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463201102400417     Document Type: Article

References (29)

1. Uhl GR, Sora I, Wang Z. The μ opiate receptor as a candidate gene for pain: polymorphisms, variations in expression, nociception, and opiate responses. Proc Natl Acad Sci USA 1999; 96:7752-5. (Pubitemid 29328353)
2. Lötsch J, Geisslinger G. Are mu-opioid receptor polymorphisms important for clinical opioid therapy? Trends Mol Med 2005; 11:82-9. (Pubitemid 40193487)
3. Bond C, LaForge KS, Tian M, et al. Single nucleotide polymorphism in the human μ opioid receptor gene alters beta-endorphin binding and activity: Possible implications for opiate addiction. Proc Natl Acad Sci USA 1998; 95:9608-13. (Pubitemid 28506279)
4. Klepstad P, Rakvåg TT, Kaasa S, et al. The 118A>G polymorphism in the human m-opioid receptor gene may increase morphine requirements in patients with pain caused by malignant disease. Acta Anaesthesiol Scand 2004; 48:1232-39.
5. Stamer UM, Stüber F. Genetic factors in pain and its treatment. Curr Opin Anaesthesiol 2007; 20:478-84. (Pubitemid 47415138)
6. Beyer A, Koch T, Schröder H, Schulz S, Höllt V. Effect of the A118G polymorphism on binding affinity, potency and agonist-mediated endocytosis, desensitization, and resensitization of the human μ-opioid receptor. J Neurochem 2004; 89:553-60. (Pubitemid 38534141)
7. Zhang Y, Wang D, Johnson AD, Papp AC, Sadée W. Allelic expression imbalance of human μ opioid receptor (OPRM1) caused by variant A118G. J Biol Chem 2005; 280:32618-24. (Pubitemid 41368304)
8. Margas W, Zubkoff I, Schuler HG, Janicki PK, Ruiz-Velasco V. Modulation of Ca2+ channels by heterologously expressed wild-type and mutant human micro-opioid receptors (hMORs) containing the A118G single-nucleotide polymorphism. J Neurophysiol 2007; 97:1058-67. (Pubitemid 46239487)
9. Oertel BG, Kettner M, Scholich K, Renné C, Roskam B, Geisslinger G, Schmidt PH, Lötsch J. A common human micro-opioid receptor genetic variant diminishes the receptor signaling efficacy in brain regions processing the sensory information of pain. J Biol Chem 2009, 6; 284:6530-5.
10. Chong RY, Oswald L, Yang X, Uhart M, Lin PI, Wand GS. The Micro-opioid receptor polymorphism A118G predicts cortisol responses to naloxone and stress. Neuropsychopharmacology 2006; 31:204-11. (Pubitemid 43250957)
11. Hernandez-Avila CA, Wand G, Luo X, Gelernter J, Kranzler HR. Association between the cortisol response to opioid blockade and the Asn40Asp polymorphism at the μ-opioid receptor locus (OPRM1). Am J Med Genet B Neuropsychiatr Genet 2003; 118B:60-5. (Pubitemid 37064077)
12. Wand GS, McCaul M, Yang X, Reynolds J, Gotjen D, Lee S, Ali A. The μ-opioid receptor gene polymorphism (A118G) alters HPA axis activation induced by opioid receptor blockade. Neuropsychopharmacology 2002; 26:106-14. (Pubitemid 34075281)
13. Ikeda K, Ide S, Han W, Hayashida M, Uhl GR, Sora I. How individual sensitivity to opiates can be predicted by gene analyses. Trends Pharmacol Sci 2005; 26:311-7. (Pubitemid 40733524)
14. Savoia G, Ambrosio F, Paoletti F, et al.: SIAARTI Study Group for Acute/Chronic Pain. SIAARTI recommendations for the treatment of postoperative pain. Minerva Anestesiol 2002; 68:735-50. (Pubitemid 41739174)
15. Kreek MJ, LaForge KS. Stress responsivity, addiction, and a functional variant of the human μ-opioid receptor gene. Mol Interv 2007; 7:74-8.
16. Kroslak T, Laforge KS, Gianotti RJ, Ho A, Nielsen DA, Kreek MJ. The single nucleotide polymorphism A118G alters functional properties of the human μ opioid receptor. J Neurochem 2007; 103:77-87. (Pubitemid 47404205)
17. Lötsch J, Skarke C, Grösch S, Darimont J, Schmidt H, Geisslinger G. The polymorphism A118G of the human μ-opioid receptor gene decreases the pupil constrictory effect of morphine-6-glucuronide but not that of morphine. Pharmacogenetics 2002; 12:3-9. (Pubitemid 34112237)
18. Romberg RR, Olofsen E, Bijl H, Taschner PE, Teppema LJ, Sarton EY, van Kleef JW, Dahan A. Polymorphism of μ-opioid receptor gene (OPRM1: c.118A>G) does not protect against opioid-induced respiratory depression despite reduced analgesic response. Anesthesiology 2005; 102:522-30. (Pubitemid 40315140)
19. Chou WY, Yang LC, Lu HF, Ko JY, Wang CH, Lin SH, Lee TH, Concejero A, Hsu CJ. Association of μ-opioid receptor gene polymorphism (A118G) with variations in morphine consumption for analgesia after total knee arthroplasty. Acta Anaesthesiol Scand 2006; 50:787-92. (Pubitemid 44034227)
20. Chou WY, Wang CH, Liu PH, Liu CC, Tseng CC, Jawan B. Human opioid receptor A118G polymorphism affects intravenous patient-controlled analgesia morphine consumption after total abdominal hysterectomy. Anesthesiology 2006; 105:334-7. (Pubitemid 44148178)
21. Hayashida M, Nagashima M, Satoh Y, et al. Analgesic requirements after major abdominal surgery are associated with OPRM1 gene polymorphism genotype and haplotype. Pharmacogenomics 2008; 9:1605-16.
22. Janicki PK, Schuler G, Francis D, Bohr A, Gordin V, Jarzembowski T, Ruiz-Velasco V, Mets B. A genetic association study of the functional A118G polymorphism of the human μ-opioid receptor gene in patients with acute and chronic pain. Anesth Analg 2006; 103:1011-7. (Pubitemid 44576714)
23. Landau R, Kern C, Columb MO, Smiley RM, Blouin JL. Genetic variability of the μ-opioid receptor influences intrathecal fentanyl analgesia requirements in laboring women. Pain 2008; 139:5-14.
24. Wand GS, Schumann H. Relationship between plasma adrenocorticotropin, hypothalamic opioid tone, and plasma leptin. J Clin Endocrinol Metab 1998; 83:2138-42. (Pubitemid 28496350)
25. Bart G, LaForge KS, Borg L, Lilly C, Ho A, Kreek MJ. Altered levels of basal cortisol in healthy subjects with a 118G allele in exon 1 of the μ opioid receptor gene. Neuropsychopharmacology 2006; 31:2313-7. (Pubitemid 44413212)
26. Hernandez-Avila CA, Covault J, Wand G, Zhang H, Gelernter J, Kranzler HR. Population-specific effects of the Asn40Asp polymorphism at the μ-opioid receptor gene (OPRM1) on HPA-axis activation. Pharmacogenet Genomics 2007; 17:1031-8. (Pubitemid 351339487)
27. Lötsch J, Geisslinger G, Tegeder I. Genetic modulation of the pharmacological treatment of pain. Pharmacol Therapeutics 2009; 124:168-84.
28. Lötsch J, Geisslinger G. A critical appraisal of human genotyping for pain therapy. Trends Pharmacol Sci 2010; 31:312-17.
29. Walter C, Lotsch J. Meta-analysis of the relevance of the OPRM1 118A>G genetic variant for pain treatment. Pain 2009; 146:270-75.